期刊文献+

AD样大鼠模型海马内PSD-95表达与学习记忆变化的研究 被引量:2

Study on changes of learning and memory functions and PSD-95 expression in hippocampus of AD-like rats
下载PDF
导出
摘要 目的:研究阿尔茨海默病(AD)样大鼠模型海马内突触后致密物-95(PSD-95)表达与学习记忆损伤的元素。方法:健康成年雄性SD大鼠随机分为正常对照组、模型对照组和AD模型组。AD样大鼠模型的建立采用Aβ1-40/Al Cl3双干预法。采用Morris水迷宫和跳台实验检测大鼠的学习记忆能力,采用刚果红染色和尼氏染色观察大鼠海马病理变化,采用免疫印迹的方法检测大鼠海马PSD-95的表达情况。结果:与正常对照组和模型对照组相比,AD模型组大鼠Morris水迷宫逃避潜伏期明显延长(P<0.05),跳台实验的反应时间、基础错误次数和错误次数均增加,潜伏期缩短(P<0.05)。AD模型组大鼠海马可观察到明显的病理改变,正常对照组和模型对照组中则观察不到。与正常对照组和模型对照组相比,AD模型组大鼠海马PSD-95的表达明显降低(P<0.05)。结论:PSD-95在AD样大鼠海马表现为病理性低表达,并且这种病理性低表达很可能与AD样学习记忆损伤存在联系。 Objective: To study relatianship of PSD-95 expression in hippocampus of Alzheimer's disease-like rats and learning and memory functions. Methods: The healthy aged male SD rats were randomly devided into normal control,model control and AD-like model groups. Aβ1-40 and Al Cl3 were used to establish AD-like model. Morris water maze test and step-down test were used to detect the learning and memory function of rats,Congo red and Nissl staning were used to observe the pathology of rats' hippocampus and Western Blotting was used to detect the expression of PSD-95 in each group. Results: Compared with normal control and model control,the water maze test escape latency of AD model rats was longer( P〈 0. 05),the test learning time,basal number of errors and number of errors of step-down were increased and the latency period was decreased( P〈 0. 05). Pathologit changes could be observed in rats' hippocampus,not in normal control group and model control group. Compared with normal control group and model control group,the expression of PSD-95 in AD model group was decreased( P〈 0. 05). Conclusion: Expression of PSD-95 was decreased in AD-like rat hippocampus. This decreased expression might involve in the AD-like learning and memory deficits.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2016年第2期217-222,共6页 Chinese Journal of Neuroanatomy
基金 杭州市科技计划重点专科专项课题(20120533Q41) 徐州医学院院长基金(2012KJZ08)
关键词 阿尔茨海默病 PSD-95 海马 大鼠 Alzheimer's disease PSD-95 hippocampus rat
  • 相关文献

参考文献21

  • 1Bloom GS.Amyloid-βand Tau:the trigger and bullet in Alzheimer disease pathogenesis[J].JAMA Neurol,2014,71:505-508.
  • 2Dickerson BC,Wolk DA.Alzheimer’s Disease Neuroimaging Initiative.Biomarker-based prediction of progression in MCI:Comparison of AD signature and hippocampal volume with spinal fluid amyloid-βand Tau[J].Front Aging Neurosci,2013,5:55.
  • 3Strac DS,Muck-Seler D,Pivac N.Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer’s disease:a review[J].Psychiatr Danub,2015,27:14-24.
  • 4Mota SI,Ferreira IL,Rego AC.Dysfunctional synapse in Alzheimer’s disease-A focus on NMDA receptors[J].Neuropharmacology,2014,76:16-26.
  • 5Le Blanc BW,Iwata M,Mallon AP,et al.A cyclic peptide targeted against PSD-95 blocks central sensitization and attenuates thermal hyperalgesia[J].Neuroscience,2010,167:490-500.
  • 6Florio SK,Loh C,Huang SM,et al.Disruption of n NOS-PSD95protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents[J].Br J Pharmacol,2009,158:494-506.
  • 7Ittner LM,Ke YD,Delerue F,et al.Dendritic function of Tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models[J].Cell,2010,142:387-397.
  • 8刘志安,赵娓娓,马凯,吕春娥,徐铁军.β淀粉样蛋白1-40和氯化铝双干预阿尔茨海默病大鼠模型的建立[J].中国组织工程研究与临床康复,2010,14(37):6917-6921. 被引量:13
  • 9George P,Charles W.The rat brain in stereotaxic coordinates[M].6th ed.London:Elsevier Inc,2007:13-97.
  • 10Armstrong RA.A critical analysis of the’amyloid cascade hypothesis’[J].Folia Neuropathol,2014,52:211-225.

二级参考文献24

  • 1冯荣芳,冯亚青,吕佩源.阿尔茨海默病动物模型研究进展[J].脑与神经疾病杂志,2008,16(6):724-726. 被引量:17
  • 2Da-Bing LI,Jun TANG,Xiao-Tang FAN,Min SONG,Hai-Wei XU,Yun BAI.Comparative study of histopathology changes between the PS1/APP double transgenic mouse model and Aβ_(1-40)-injected rat model of Alzheimer disease[J].Neuroscience Bulletin,2006,22(1):52-57. 被引量:7
  • 3Kowalska A. The beta-amyloid cascade hypothesis: a se- quence of events leading to neurodegeneration in Alzhei- mer's disease E J ]. Nettral Neurochir Pol, 2004, 38 ( 5 ) : 405-411.
  • 4Gilbert B J. The role of amyloid 13 in the pathogenesis of Alzheimer's disease m J]. J Clin Pathol, 2013, 66 ( 5 ) : 362-366.
  • 5Working Group. Consensus recommendations for the post- mortem diagnosis of Alzheimer's disease, The national in- stitute on aging and reagon institute working group on di- agnostic criteria for the neuropathological assessment of Alzheimer's disease E J ]. Neurobiol Aging, 1997, 18 (4 Suppl) :S1-2.
  • 6Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer's disease[ J]. Alzheimers Dement, 2007, 3(3):186-191.
  • 7Hudmon A, Schulman H. Neuronal Ca2 ~/calmodulin-de- pendent protein kinase II: the role of structure and auto- regulation in cellular function [ J ]. Annu Rev Biochem, 2002, 71:473-510.
  • 8Kennedy M B, Greengard P. Two calcium/calmodulin- dependent protein kinases, which are highly concentrated in brain, phosphorylate protein I at distinct sites [ J ]. Proc Natl Acad Sci U S A, 1981, 78(2) :1293-1297.
  • 9Lisman J, Schulman H, Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory [J]. Nat Rev Neurosci, 2002, 3(3) :175-190.
  • 10Yamauchi T, Fujisawa H. Evidence for three distinct forms of calmodulin-dependent protein kinases from rat brainEJ]. FEBS Lett, 1980, 116(2) :141-144.

共引文献17

同被引文献9

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部